This bill amends various sections of the Idaho Code concerning controlled substances, particularly focusing on the classifications of Schedule I, Schedule III, and Schedule IV substances. It introduces numerous new substances to Schedule I, including various fentanyl analogs and synthetic opioids, such as Alpha'-methyl butyryl fentanyl and 2',5'-Dimethoxyfentanyl, while deleting outdated or less relevant substances from the existing list. The bill also proposes amendments to the classifications of synthetic drugs and their analogs, adding compounds like Cumyl PeGACLONE, 5F-EDMB-PICA, and MDMB-4EN-PINACA, and updates the language to reflect current understandings of these substances and their potential for abuse.

Additionally, the bill addresses the classification of anabolic steroids, introducing new substances such as various forms of androstenedione and androgens, while removing some previously listed substances. It specifies that anabolic steroids intended for nonhuman species and approved by the FDA will not be classified as controlled substances. The legislation establishes penalties for the unauthorized prescription, dispensing, or possession of anabolic steroids or human growth hormones for performance enhancement, categorizing these actions as felonies. The bill is set to take effect on July 1, 2025, following the declaration of an emergency, highlighting the urgency of addressing the opioid crisis and the regulation of emerging synthetic drugs.

Statutes affected:
Bill Text: 37-2705, 37-2709, 37-2711